|
|
 |
|
Viewing report
|
|
|
|
IMS World Review Country Profile - China Hospital
IMS Health, July 2007, Pages: 50
IMS Health’s Country Profiles provide a comprehensive insight into the national sales of the pharmaceutical market in selected countries over 5 years. Each individual IMS Company Profile analyzes the critical components that make up a pharmaceutical company, providing you with a clear assessment of the relative strengths and weaknesses of a company’s business strategy. Sales performance is analysed in terms of geographic region, major corporations, therapeutic classes, major products and new product activity.
All data is available over a 5 year period for easy trend analysis and is based on Quarter 4 sales figures.
Country Profiles are available for:
Argentina, Australia, Austria, Belgium, Brazil, Canada, China, Czech Republic, Egypt, Finland, France, Germany, India, Indonesia, Italy, Mexico, Netherlands, Poland, Portugal, Russian Federation, South Africa, South Korea, Spain, Switzerland, Taiwan, Turkey, United Kingdom and United States.
Products Mentioned:
AI SU
CELLCEPT
DA LI XIN
GLUCOBAY
KAI LUO XIN
LOSEC
NOVOLIN 30R
PLAVIX
TIENAM
ZUO KE
Customers who bought this item also bought
IMS Health - SWOT Analysis
Tianjin Zhong Xin Pharmaceutical Group Corporation Limited
Min Xin Holdings Ltd.
Xin Jiang Bai Hua Cun Company
IMS Health Incorporated
IMS MAXIMS PLC
The 2009-2014 Outlook for Infrastructure Management Services (IMS) in the United States
The 2009-2014 Outlook for Infrastructure Management Services (IMS) in Greater China
The 2009-2014 Outlook for Infrastructure Management Services (IMS) in Asia & Oceana
The 2009-2014 Outlook for Infrastructure Management Services (IMS) in Africa
The 2009-2014 Outlook for Infrastructure Management Services (IMS) in The Middle East
The 2009-2014 Outlook for Infrastructure Management Services (IMS) in North America & the Caribbean
|
|
|
|
